Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

Pay 465 Times More For H1B Visa! IT Stocks In Focus

Pay 465 Times More For H1B Visa! IT Stocks In Focus

'70% Of H-1B Visa Holders Are Indians,' Says Visa Consultant Bikram Chabhal On US Visa Fee Hike

'70% Of H-1B Visa Holders Are Indians,' Says Visa Consultant Bikram Chabhal On US Visa Fee Hike

Ola Electric Gears Up For Festive Season, Aiming To Slash Vehicle Delivery Timelines

Ola Electric Gears Up For Festive Season, Aiming To Slash Vehicle Delivery Timelines

Inflation Rates Based On The All-India Consumer Price Index For Agricultural & Rural Labourers For...

Inflation Rates Based On The All-India Consumer Price Index For Agricultural & Rural Labourers For...

Rajasthan's Nuclear Renaissance: Second Power Plant Set To Propel State To 6,680 MW Milestone After...

Rajasthan's Nuclear Renaissance: Second Power Plant Set To Propel State To 6,680 MW Milestone After...